T2	Concept 33 49	human telomerase
T3	Action 58 63	found
T4	Concept 85 94	PK region
T5	Concept 102 105	RNA
T6	Concept 5 25	pathogenic mutations
A1	Emphasized T6
R1	subject Arg1:T3 Arg2:T6	
T1	Concept 150 152	PK
T7	Concept 50 53	RNA
R2	has-part Arg1:T7 Arg2:T2	
T8	Concept 71 84	wellconserved
R3	has-part Arg1:T5 Arg2:T4	
R4	has-property Arg1:T4 Arg2:T8	
T9	Concept 173 180	current
T10	Concept 181 193	confirmation
T11	Concept 197 207	SARS-CoV-2
T12	Concept 208 217	infection
R5	is-a Arg1:T11 Arg2:T12	
R6	in-time Arg1:T10 Arg2:T9	
T13	Action 230 235	based
R7	subject Arg1:T13 Arg2:T10	
A2	Emphasized T13
T14	Concept 243 320	viral real-time reverse transcription polymerase chain reaction (RT-PCR) test
R8	target Arg1:T13 Arg2:T14	
R9	target Arg1:T3 Arg2:T4	
T15	Concept 321 327	result
R10	causes Arg1:T14 Arg2:T15	
T16	Concept 334 343	mortality
T17	Concept 351 355	PEDV
T18	Concept 356 365	infection
R11	is-a Arg1:T17 Arg2:T18	
T19	Action 366 368	is
T20	Concept 369 374	lower
R12	target Arg1:T19 Arg2:T20	
T21	Concept 378 383	older
T22	Concept 384 388	pigs
R13	has-property Arg1:T22 Arg2:T21	
R14	subject Arg1:T19 Arg2:T16	
T23	Action 410 416	result
A3	Uncertain T23
T24	Concept 390 399	infection
R15	subject Arg1:T23 Arg2:T24	
T25	Concept 430 448	growth performance
A4	Diminished T25
R16	target Arg1:T23 Arg2:T25	
R17	causes Arg1:T17 Arg2:T16	
T26	Concept 449 453	ACE2
T27	Action 464 473	expressed
A5	Emphasized T27
T28	Concept 477 486	AT2 cells
R18	target Arg1:T27 Arg2:T28	
T29	Action 496 504	detected
T30	Concept 508 517	AT1 cells
T31	Concept 519 542	airway epithelial cells
T32	Concept 544 555	fibroblasts
T33	Concept 557 574	endothelial cells
T34	Concept 580 591	macrophages
R19	target Arg1:T29 Arg2:T30	
R20	subject Arg1:T29 Arg2:T26	
R21	subject Arg1:T27 Arg2:T26	
R22	target Arg1:T29 Arg2:T31	
R23	target Arg1:T29 Arg2:T32	
R24	target Arg1:T29 Arg2:T33	
R25	target Arg1:T29 Arg2:T34	
T35	Concept 616 623	Ce:GAGG
T36	Concept 624 632	crystals
R26	is-a Arg1:T35 Arg2:T36	
T37	Concept 605 615	rod-shaped
R27	has-property Arg1:T35 Arg2:T37	
T39	Action 687 697	activation
T40	Concept 701 712	glial cells
T41	Action 633 642	implanted
T42	Concept 662 672	four weeks
R29	subject Arg1:T41 Arg2:T35	
R30	in-time Arg1:T41 Arg2:T42	
R31	causes Arg1:T41 Arg2:T39	
A6	Negated T39
R28	target Arg1:T39 Arg2:T40	
T38	Concept 749 761	optic fibers
T43	Concept 735 748	biocompatible
R32	has-property Arg1:T38 Arg2:T43	
